| Primary |
| Burkitt's Lymphoma |
16.5% |
| Epilepsy |
11.8% |
| Addison's Disease |
10.6% |
| Acute Monocytic Leukaemia |
9.4% |
| Acute Respiratory Distress Syndrome |
7.1% |
| Crohn's Disease |
5.9% |
| Prostate Cancer |
4.7% |
| Chemotherapy |
3.5% |
| Hormone Replacement Therapy |
3.5% |
| Tinnitus |
3.5% |
| Adrenal Cortical Insufficiency |
2.4% |
| Analgesia |
2.4% |
| Bladder Disorder |
2.4% |
| Cardiomyopathy |
2.4% |
| Constipation |
2.4% |
| Diabetes Mellitus Insulin-dependent |
2.4% |
| Haemorrhoids |
2.4% |
| Hypertension |
2.4% |
| Hypopituitarism |
2.4% |
| Laryngeal Disorder |
2.4% |
|
| Pyrexia |
10.9% |
| Poor Quality Drug Administered |
9.1% |
| Transplant Rejection |
9.1% |
| Loss Of Consciousness |
7.3% |
| Adrenocortical Insufficiency Acute |
5.5% |
| Overdose |
5.5% |
| Vomiting |
5.5% |
| Drug Ineffective |
3.6% |
| Food Poisoning |
3.6% |
| Hypersensitivity |
3.6% |
| Hyponatraemia |
3.6% |
| Hypoxia |
3.6% |
| Liver Transplant Rejection |
3.6% |
| Pain In Extremity |
3.6% |
| Phaeochromocytoma |
3.6% |
| Posterior Capsule Opacification |
3.6% |
| Psychotic Disorder |
3.6% |
| Renal Failure Acute |
3.6% |
| Respiratory Distress |
3.6% |
| Skin Test Positive |
3.6% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
14.8% |
| Acute Respiratory Distress Syndrome |
14.8% |
| Adult T-cell Lymphoma/leukaemia |
6.5% |
| Asthma |
6.5% |
| Precursor B-lymphoblastic Lymphoma |
6.2% |
| T-cell Lymphoma |
5.5% |
| Drug Use For Unknown Indication |
5.2% |
| B Precursor Type Acute Leukaemia |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Behcet's Syndrome |
4.6% |
| Bacteraemia |
3.7% |
| Addison's Disease |
3.1% |
| Hypertension |
3.1% |
| Immunosuppressant Drug Therapy |
3.1% |
| Rheumatoid Arthritis |
2.5% |
| Tinnitus |
2.5% |
| Vomiting |
2.5% |
| Skin Test |
2.2% |
| Candidiasis |
1.8% |
| Chemotherapy |
1.8% |
|
| Staphylococcal Mediastinitis |
19.5% |
| Adrenocortical Insufficiency Acute |
11.0% |
| Pyrexia |
9.8% |
| Skin Test Positive |
8.5% |
| Weight Increased |
6.1% |
| Food Poisoning |
4.9% |
| Renal Disorder |
4.9% |
| Pneumonia Cytomegaloviral |
3.7% |
| Trichosporon Infection |
3.7% |
| Vomiting |
3.7% |
| Drug Eruption |
2.4% |
| Drug Ineffective |
2.4% |
| Hypotension |
2.4% |
| Mitral Valve Incompetence |
2.4% |
| Nervous System Disorder |
2.4% |
| Pneumonia Staphylococcal |
2.4% |
| Pneumothorax |
2.4% |
| Posterior Capsule Opacification |
2.4% |
| Somnolence |
2.4% |
| Subarachnoid Haemorrhage |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.4% |
| Product Used For Unknown Indication |
9.1% |
| Prophylaxis |
6.3% |
| Acute Lymphocytic Leukaemia |
6.2% |
| Sedation |
4.8% |
| Shock |
4.8% |
| Infection |
4.7% |
| Schizophrenia |
4.7% |
| Hypertension |
4.5% |
| Fluid Replacement |
4.4% |
| Acute Myeloid Leukaemia |
4.0% |
| Sepsis |
3.6% |
| Non-small Cell Lung Cancer |
3.1% |
| Blood Corticotrophin Decreased |
2.9% |
| Analgesic Therapy |
2.8% |
| B-cell Lymphoma |
2.8% |
| Primary Hypothyroidism |
2.8% |
| Acth Decreased |
2.7% |
| Crohn's Disease |
2.3% |
| Hypothyroidism |
2.3% |
|
| Vomiting |
11.6% |
| Pancytopenia |
8.9% |
| Pyrexia |
8.9% |
| Cardiac Failure |
6.3% |
| Somnolence |
6.3% |
| Febrile Neutropenia |
5.4% |
| Thrombocytopenia |
5.4% |
| Pneumonia |
4.5% |
| Psychiatric Symptom |
4.5% |
| Renal Impairment |
4.5% |
| Respiratory Distress |
4.5% |
| Tremor |
4.5% |
| Gangrene |
3.6% |
| Respiratory Failure |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Convulsion |
2.7% |
| Electrocardiogram Qt Prolonged |
2.7% |
| Fall |
2.7% |
| Gastroenteritis Viral |
2.7% |
|
